Schonfeld Strategic Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-257,419
| Closed | -$15.3M | – | 2249 |
|
|
2025
Q4 | $15.3M | Sell |
257,419
-217,979
| -46% | -$11.9M | 0.08% | 254 |
|
|
2025
Q3 | $25.7M | Buy |
475,398
+244,243
| +106% | +$14M | 0.18% | 137 |
|
|
2025
Q2 | $12.7M | Sell |
231,155
-31,701
| -12% | -$1.87M | 0.1% | 271 |
|
|
2025
Q1 | $18.6M | Buy |
262,856
+251,756
| +2,268% | +$16.9M | 0.12% | 182 |
|
|
2024
Q4 | $730K | Sell |
11,100
-19,548
| -64% | -$1.31M | ﹤0.01% | 1256 |
|
|
2024
Q3 | $2.15M | Sell |
30,648
-173,784
| -85% | -$14.5M | 0.02% | 848 |
|
|
2024
Q2 | $16.8M | Buy |
204,432
+21,940
| +12% | +$1.83M | 0.13% | 203 |
|
|
2024
Q1 | $15.9M | Buy |
182,492
+11,332
| +7% | +$1.01M | 0.13% | 228 |
|
|
2023
Q4 | $16.5M | Buy |
171,160
+76,159
| +80% | +$6.74M | 0.14% | 204 |
|
|
2023
Q3 | $8.41M | Buy |
95,001
+36,574
| +63% | +$3.25M | 0.08% | 392 |
|
|
2023
Q2 | $5.06M | Buy |
58,427
+45,540
| +353% | +$4.29M | 0.04% | 483 |
|
|
2023
Q1 | $1.25M | Sell |
12,887
-57,400
| -82% | -$5.95M | 0.01% | 862 |
|
|
2022
Q4 | $7.27M | Sell |
70,287
-26,569
| -27% | -$2.49M | 0.06% | 377 |
|
|
2022
Q3 | $8.21M | Buy |
96,856
+94,063
| +3,368% | +$8.38M | 0.07% | 373 |
|
|
2022
Q2 | $231K | Sell |
2,793
-35,407
| -93% | -$2.82M | ﹤0.01% | 1807 |
|
|
2022
Q1 | $2.94M | Buy |
+38,200
| New | +$3.2M | 0.03% | 606 |
|
|
2021
Q4 | – | Sell |
-29,300
| Closed | -$2.27M | – | 2158 |
|
|
2021
Q3 | $2.27M | Buy |
+29,300
| New | +$2.31M | 0.03% | 676 |
|
|
2021
Q1 | – | Sell |
-18,541
| Closed | -$1.63M | – | 1809 |
|
|
2020
Q4 | $1.63M | Buy |
18,541
+13,788
| +290% | +$1.09M | 0.02% | 657 |
|
|
2020
Q3 | $362K | Sell |
4,753
-4,735
| -50% | -$479K | 0.01% | 1022 |
|
|
2020
Q2 | $1.17M | Buy |
9,488
+3,138
| +49% | +$312K | 0.03% | 565 |
|
|
2020
Q1 | $537K | Buy |
+6,350
| New | +$547K | 0.03% | 557 |
|
|
2019
Q4 | – | Sell |
-44,700
| Closed | -$3.01M | – | 1292 |
|
|
2019
Q3 | $3.01M | Buy |
44,700
+37,000
| +481% | +$2.85M | 0.09% | 237 |
|
|
2019
Q2 | $660K | Buy |
+7,700
| New | +$659K | 0.02% | 562 |
|
|
2018
Q4 | – | Sell |
-16,900
| Closed | -$1.64M | – | 1062 |
|
|
2018
Q3 | $1.64M | Sell |
16,900
-68,900
| -80% | -$6.88M | 0.07% | 327 |
|
|
2018
Q2 | $8.08M | Buy |
+85,800
| New | +$7.51M | 0.44% | 50 |
|
|
2017
Q3 | – | Sell |
-8,093
| Closed | -$735K | – | 602 |
|
|
2017
Q2 | $735K | Buy |
+8,093
| New | +$736K | 0.08% | 328 |
|
|
2017
Q1 | – | Sell |
-6,434
| Closed | -$533K | – | 600 |
|
|
2016
Q4 | $533K | Buy |
+6,434
| New | +$553K | 0.07% | 329 |
|
|
2016
Q3 | – | Sell |
-38,607
| Closed | -$3M | – | 421 |
|
|
2016
Q2 | $3M | Buy |
+38,607
| New | +$3.28M | 0.67% | 28 |
|
Other funds holding BMRN
VCM
VPM
